Mylan Sold Its Soul – Will Your Sales Team?
OpenSymmetry
NOVEMBER 3, 2016
From executive compensation and incentive strategies to the legislative framework, we will dissect this case to address the fact that this is not just a problem plaguing Big Pharma, but any entity that drives people within the organization to a goal through incentive compensation. Is this just a story of greed? Yes and no.
Let's personalize your content